AR036179A1 - Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla - Google Patents

Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla

Info

Publication number
AR036179A1
AR036179A1 ARP020102695A ARP020102695A AR036179A1 AR 036179 A1 AR036179 A1 AR 036179A1 AR P020102695 A ARP020102695 A AR P020102695A AR P020102695 A ARP020102695 A AR P020102695A AR 036179 A1 AR036179 A1 AR 036179A1
Authority
AR
Argentina
Prior art keywords
prepare
treatment
pharmaceutical composition
pulmonary disease
chronic obstructive
Prior art date
Application number
ARP020102695A
Other languages
English (en)
Inventor
K Sekiguchi
K Ikezono
K Ohta
T Maeda
H Nagamoto
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR036179A1 publication Critical patent/AR036179A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Composición farmacéutica para el tratamiento de una enfermedad pulmonar obstructiva crónica, que comprende, como ingrediente eficaz, por lo menos un compuesto seleccionado del grupo que consiste en derivados de tiazol y sales de los mismos representadas por la fórmula general (1), en donde: R1 es un grupo fenilo que puede tener de 1 a 3 grupos alcoxilo inferior como sustituyentes en el anillo fenilo; R2 es un grupo piridilo que puede tener de 1 a 3 grupos carboxilo como sustituyentes en el anillo de piridina; y un portador farmacéuticamente aceptable. Preferentemente, el derivado de tiazol es ácido 6-[2-(3,4-dietoxifenil)-tiazol-4-il]piridin-2-carboxílico. Uso de por lo menos un compuesto seleccionado del grupo que consiste en derivados de tiazol y sales de los mismos para preparar dicha composición.
ARP020102695A 2001-07-24 2002-07-18 Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla AR036179A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001222768 2001-07-24

Publications (1)

Publication Number Publication Date
AR036179A1 true AR036179A1 (es) 2004-08-18

Family

ID=19056195

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP020102695A AR036179A1 (es) 2001-07-24 2002-07-18 Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla
ARP130101121A AR090619A2 (es) 2001-07-24 2013-04-05 Uso de un compuesto de tiazol para la produccion de un medicamento

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP130101121A AR090619A2 (es) 2001-07-24 2013-04-05 Uso de un compuesto de tiazol para la produccion de un medicamento

Country Status (16)

Country Link
US (2) US20040147563A1 (es)
EP (1) EP1411936B1 (es)
KR (1) KR100566709B1 (es)
CN (1) CN1267097C (es)
AR (2) AR036179A1 (es)
AT (1) ATE305299T1 (es)
BR (1) BR0208719A (es)
CA (1) CA2441804C (es)
DE (1) DE60206391T2 (es)
DK (1) DK1411936T3 (es)
ES (1) ES2249596T3 (es)
HK (1) HK1077216A1 (es)
MX (1) MXPA04000620A (es)
MY (1) MY128711A (es)
TW (1) TWI302456B (es)
WO (1) WO2003009844A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
TWI436761B (zh) * 2006-06-19 2014-05-11 Otsuka Pharma Co Ltd 使用噻唑衍生物之方法
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245660T3 (es) 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
AU4015497A (en) * 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6727364B2 (en) * 2001-04-30 2004-04-27 The Procter & Gamble Company Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Also Published As

Publication number Publication date
AR090619A2 (es) 2014-11-26
CA2441804C (en) 2007-05-08
CN1633295A (zh) 2005-06-29
DE60206391T2 (de) 2006-07-13
DE60206391D1 (de) 2006-02-09
WO2003009844A1 (en) 2003-02-06
EP1411936B1 (en) 2005-09-28
HK1077216A1 (en) 2006-02-10
CA2441804A1 (en) 2003-02-06
US20040147563A1 (en) 2004-07-29
KR20040028749A (ko) 2004-04-03
MY128711A (en) 2007-02-28
MXPA04000620A (es) 2004-06-25
TWI302456B (en) 2008-11-01
KR100566709B1 (ko) 2006-04-03
DK1411936T3 (da) 2005-12-27
EP1411936A1 (en) 2004-04-28
CN1267097C (zh) 2006-08-02
BR0208719A (pt) 2004-07-20
ES2249596T3 (es) 2006-04-01
US7932276B2 (en) 2011-04-26
US20080081828A1 (en) 2008-04-03
ATE305299T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
RU2007148994A (ru) Композиции и способы лечения заболевания сетчатки
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
EA200602170A1 (ru) Производные пиперидина, композиции на их основе, способы их применения
JP2004502756A5 (es)
AR053790A1 (es) Acidos biariloximetilarencarboxilicos. procesos de obtencion y composiciones farmaceuticas.
CO5640098A2 (es) Acidos biariloximetilaren-carboxilicos
EA200602019A1 (ru) Производные пиперазина и их применение для борьбы с вредителями
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
MX2009010790A (es) Derivados de heteroarilo biciclico fusionados.
RU2005105564A (ru) Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
AR057558A1 (es) Compuestos de cinolincarboxamida y composicion farmaceutica
AR090619A2 (es) Uso de un compuesto de tiazol para la produccion de un medicamento
AR032598A1 (es) Oxazinquinolonas, una composicion farmaceutica y el uso de las mismas para preparar un medicamento utiles en el tratamiento de infecciones virales
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
RU2010141996A (ru) Ингибитор ммр-2 и/или ммр-9
PT1050531E (pt) Compostos piridinicos ou piperidinicos substituidos para o tratamento de doencas neurodegenerativas
AR045548A1 (es) Derivados de imidazol
JP2019504834A5 (es)
NO20033660D0 (no) HIV inhibitere N-aminoimidazolderivativer
TH64474A (th) สารสำหรับรักษาโรคปอดอุดกั้นเรื้อรัง
BR0317244A (pt) Derivados de piperazina contendo fósforo como antagonistas ccr1
AR045998A1 (es) Preparacion para enema
RU2003103097A (ru) Пиперидиновые производные, предназначенные для применения в качестве ингибиторов ccr-3

Legal Events

Date Code Title Description
FC Refusal